Full Text View
Tabular View
Study Results
Related Studies
An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain
This study has been completed.
Study NCT01202227   Information provided by Pfizer

First Received on August 31, 2010.   Last Updated on April 5, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Spinal Cord Diseases
Spinal Cord Injuries
Neuralgia
Pain
More general conditions related to this trial
Central Nervous System Diseases
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Diseases
Peripheral Nervous System Diseases
Signs and Symptoms
Trauma, Nervous System
Wounds and Injuries
Interventions listed in this trial
pregabalin
More general drug interventions related to this trial
Analgesics
Anticonvulsants
Central Nervous System Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services